Enriched in OLL; PVD; head mesodermal cell; and sensory neurons based on microarray and RNA-seq studies. Is affected by several genes including
daf-16;
let-60; and
let-7 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by ten chemicals including metformin; Sirolimus; and silicon dioxide nanoparticle based on RNA-seq; microarray; and proteomic studies. Human FRMPD2 enables 1-phosphatidylinositol binding activity. Is predicted to encode a protein with the following domains: PH-like domain superfamily; FERM C-terminal PH-like domain; FERM, C-terminal PH-like domain; FERM, N-terminal; FERM N-terminal domain; FERM central domain; FERM superfamily, second domain; FERM/acyl-CoA-binding protein superfamily; Ubiquitin-like domain superfamily; PDZ superfamily; Band 4.1 domain; and PDZ domain. Is an ortholog of human FRMPD2 (FERM and PDZ domain containing 2).